Transforming Cancer Screening and Diagnosis
Saving and Improving Lives

LifeTracDx® Liquid Biopsy


Innovative blood test for early detection and diagnosis of cancer
when it matters most


Cancer Screening and Monitoring Recurrence

  • For all cancers

  • In all stages

  • Minimal Residual Disease

  • Early detection of recurrence

  • Companion diagnostics - not requiring tissue

  • Provide aggressiveness of the cancer

  • Provide whole tumor DNA for sequencing

Cancer Diagnostics

Monitoring Therapy

  • Assay applicable to all cancers

  • Enhance patient selection

  • Provide prognosis at any time

  • Predict treatment response

  • Provide companion diagnostics - not requiring tissue

  • Validate drug targets

  • Deliver high quality DNA for sequencing

Streamline Drug Development and Clinical Trials

  • Predict response to new therapy in ~30 days

  • Sequential monitoring of therapy


  • Clinical trials

  • Partnering

  • Licensing